Effect of advanced glycosylation end products on the activity of integrins expressed on U937 cells

Human Immunology

Volumn 59, Issue 6, 1998, Pages 325-330

  Ivanov, G ^a   Kyurkchiev, S ^a  

^a BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED PROTEIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1;

AGING; ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HUMAN CELL; HYPERGLYCEMIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; VASCULAR DISEASE;

ANTIGENS, CD18; ANTIGENS, CD29; CELL ADHESION; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; RECEPTORS, FIBRONECTIN; SERUM ALBUMIN; TUMOR CELLS, CULTURED;

EID: 0032103967     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00018-4     Document Type: Article

References (19)

1. Bucala R., Makita Z., Koshinski T., Cerami A., Vlassara H. Lipid advanced glycosylation pathway for lipid oxidation in vivo . Proc Natl Acad Sci USA. 90:1993;6434.
2. Bucala R., Model P., Cerami A. Modification of DNA by reducing sugars a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression . Proc Natl Acad Sci USA. 81:1984;105.
3. Vlassara H., Bucala R., Striker L. Pathogenic effects of advanced glycosylation biochemical, biologic and clinical implications for diabetes and aging . Lab Invest. 70:1994;138.
4. Brownlee M. The pathological implications of protein glycation. Clin Invest Med. 18:1995;275.
5. Schmidt A.M., Hori O., Brett J., Yan S.D., Wautier J.L., Stern D. Cellular receptors for advanced glycation end products. Arterioscler Thromb. 14:1994;1521.
6. Schmidt A.M., Hasu M., Popov D., Zhang J.H., Chen J., Yan S.D., Brett J., Cao R., Kuwabara K., Costache G., Simionescu N., Simionescu M., Stern D. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci USA. 91:1994;8807.
7. Westwood M.E., Thornalley P.J. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins Comparison with glucose-derived advanced glycation endproduct-modified serum albumins . J Prot Chem. 14:1995;359.
8. Schmidt A.M., Hori O., Chen J.X., Li J.F., Crandell J., Zhang J., Cao R., Yan S.D., Brett J., Stern D. Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest. 96:1995;1395.
9. Nakayama H., Taneda S., Kuwajima S., Aoki S., Kuroda Y., Misawa K., Nakagawa S. Production and characterization of antibodies to glycation products on proteins. Biochem Biophys Res Commun. 162:1989;740.
10. Cohen M.P., Hud E. Production and characterization of monoclonal antibodies against human glycoalbumin. J Immun Methods. 117:1989;121.
11. Rothlein R., Springer T.A. The requirement for lymphocyte function associated antigen 1 in homotypic leukocyte adhesion stimulated by phorbol ester. J Exp Med. 163:1986;1132.
12. Ruppert M., Aigner S., Hubbe M., Yagita H., Altevogt P. The L1 adhesion molecule is a cellular ligand for VLA-5. J Cell Biol. 131:1995;1881.
13. Kohn R.R., Cerami A., Monnier V.M. Collagen aging in vitro by nonenzymatic glycosylation and browning. Diabetes. 33:1984;57.
14. Esposito C., Gerlach H., Brett J., Stern D., Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med. 170:1989;1387.
15. Kirstein M., Brett J., Radoff S., Ogawa S., Stern D., Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor role in vascular disease of diabetes and aging . Proc Natl Acad Sci USA. 87:1990;9010.
16. Vlassara H., Fuh H., Donnelly T., Cybulsky M. Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med. 1:1995;447.
17. Schmidt A.M., Yan S., Brett J., Mora R., Nowygrod R., Stern D. Regulation of mononuclear phagocyte migration by cell surface binding proteins for AGEs. J Clin Invest. 91:1993;2155.
18. Dustin M., Springer T.A. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol. 9:1991;2.
19. Yazaki K. Effect of glycated protein on the expression of very late antigen 5 (VLA5), a fibronectin receptor, of cultured rat mesangial cells. Nippon-Jinzo-Gakkai-Shi. 36:1994;1251.